In August and September of this year, three new studies (the ASPREE, ARRIVE, and ASCEND trials) have cast some doubt on aspirin’s place in preventing someone’s first harmful cardiovascular event. It is essential to know all the facts regarding these studies and to speak with your health care provider before making any decision regarding your use of aspirin therapy.

read more